← back to search

Matteo Pagliari

University of Padua · IT
Area of research
Infectious Diseases · Neurology
Research interest
Research focused on Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Antibody, with related work in Immune system, Virology, Titer. Notable publications include 'Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity', 'SARS-CoV-2 infection and replication in human gastric organoids', and 'Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers'.
h-index
citations
594
works
11
NIH funding
primary concept
email

Recent publications

Digitally Immune-Optimised Next-Generation Influenza H5Nx Vaccination Provides Protection with Broad Cross-Clade Neutralisation Against Global Threats
Research Square 2025cited by 0position: middledoi
Digitally Immune-Optimised Next-Generation Influenza Vaccine Provides Cross-Clade Protection Against Emerging H5Nx Viruses
Research Square 2025cited by 0position: middledoi
SARS-CoV-2 infection and replication in human gastric organoids
Nature Communications 2021cited by 83position: middledoi
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers
Clinical Chemistry and Laboratory Medicine (CCLM) 2021cited by 63position: middledoi
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
Cell Reports 2021cited by 58position: middledoi
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers
PEDIATRICS 2021cited by 57position: middledoi
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults
Frontiers in Immunology 2021cited by 53position: middledoi
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
Clinical Chemistry and Laboratory Medicine (CCLM) 2021cited by 40position: middledoi
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays
Clinica Chimica Acta 2021cited by 26position: middledoi
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
EBioMedicine 2020cited by 153position: middledoi
Helicobacter pylori Affects the Antigen Presentation Activity of Macrophages Modulating the Expression of the Immune Receptor CD300E through miR-4270
Frontiers in Immunology 2017cited by 61position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Francesco Bonfante · Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise G. Caporale7 papers (2020–2021)Alessio Bortolami · University of Padua7 papers (2020–2021)Mario Plebani · University of Padua6 papers (2020–2021)Andrea Padoan · University of Padua5 papers (2020–2021)Chiara Cosma · Centre Hospitalier Universitaire de Nîmes5 papers (2020–2021)Daniela Basso · Agenzia Regionale per la Protezione Ambientale del Piemonte3 papers (2021–2021)Carlo Giaquinto · University of Padua3 papers (2021–2021)Costanza Di Chiara · University of Padua3 papers (2021–2021)Paola Costenaro · University of Padua3 papers (2021–2021)Luisa Barzon · University of Pavia2 papers (2021–2021)Liviana Da Dalt · University of Padua2 papers (2021–2021)Anita De Rossi · University of Padua2 papers (2021–2021)Francesco Barbaro · University of Padua2 papers (2021–2021) · 2 papers (2021–2021)Claudia Santarossa · University of Padua2 papers (2021–2021)Maria Raffaella Petrara · University of Padua2 papers (2021–2021)Luigi Dall’Olmo · University of Padua2 papers (2021–2021)Daniele Donà · University of Padua2 papers (2021–2021)Laura Sciacovelli · University of Padua2 papers (2020–2021)Paolo Palma · University of Rome Tor Vergata2 papers (2021–2021)